These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3144906)

  • 1. Growth response to daily subcutaneous administration of growth hormone.
    Kikuchi K; Sudo M; Miyamoto A; Ohie T; Mori C; Mikawa H
    Acta Paediatr Jpn; 1988 Oct; 30(5):557-63. PubMed ID: 3144906
    [No Abstract]   [Full Text] [Related]  

  • 2. Should the dose of growth hormone be increased during the growth spurt of children with isolated growth hormone deficiency?
    Papagianni M; Stanhope R
    J Pediatr Endocrinol Metab; 2003; 16(8):1095-7. PubMed ID: 14594167
    [No Abstract]   [Full Text] [Related]  

  • 3. [Familial short stature].
    Igea García JM
    An Esp Pediatr; 1988 Oct; 29 Suppl 35():6-8. PubMed ID: 3272841
    [No Abstract]   [Full Text] [Related]  

  • 4. Contribution of dose and frequency of administration to the therapeutic effect of growth hormone.
    Smith PJ; Hindmarsh PC; Brook CG
    Arch Dis Child; 1988 May; 63(5):491-4. PubMed ID: 3389862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of growth hormone administered subcutaneously once or twice daily to growth hormone deficient adults.
    Laursen T; Jørgensen JO; Christiansen JS
    Clin Endocrinol (Oxf); 1994 Sep; 41(3):337-43. PubMed ID: 7525120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher plasma somatomedin A (biological) and C (immunological) levels with sc than with im growth hormone replacement therapy.
    Christiansen JS; Kastrup KW; Alberti KG; Petersen KE; Christiansen C; Orskov H
    Acta Endocrinol (Copenh); 1985 Jun; 109(2):169-72. PubMed ID: 3893007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of growth hormone therapy on spontaneous sexual development.
    Stanhope R; Albanese A; Hindmarsh P; Brook CG
    Horm Res; 1992; 38 Suppl 1():9-13. PubMed ID: 1295821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous versus intramuscular growth hormone therapy: growth and acute somatomedin response.
    Wilson DM; Baker B; Hintz RL; Rosenfeld RG
    Pediatrics; 1985 Sep; 76(3):361-4. PubMed ID: 4034296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of administration of growth hormone--an important factor in determining growth response to exogenous growth hormone.
    Hindmarsh PC; Stanhope R; Preece MA; Brook CG
    Horm Res; 1990; 33 Suppl 4():83-9. PubMed ID: 2245975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous growth hormone administration in growth-hormone-deficient children. Continuous plus pulsatile overnight versus single daily injection: effects on growth rate velocity.
    Cavallo L; De Luca F; Bernasconi S; Russo R; Zecchino C; Arrigo T
    Horm Res; 1994; 42(3):86-9. PubMed ID: 7995617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of subcutaneous and intramuscular administration of human growth hormone (hGH) and increased growth rate by daily injection of hGH in GH deficient children.
    Takano K; Shizume K; Hibi I
    Endocrinol Jpn; 1988 Jun; 35(3):477-84. PubMed ID: 3197659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single dose and pulsatile treatment with human growth hormone in growth hormone deficiency.
    Smith PJ; Pringle PJ; Brook CG
    Arch Dis Child; 1987 Aug; 62(8):849-51. PubMed ID: 3662594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catch-up growth following transfer from three times weekly im to daily sc administration of hGH in GH deficient patients, monitored by knemometry.
    Hermanussen M; Geiger-Benoit K; Sippell WG
    Acta Endocrinol (Copenh); 1985 Jun; 109(2):163-8. PubMed ID: 4013610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of two different regimens of recombinant human growth hormone therapy on the bone mineral density of patients with growth hormone deficiency.
    Zamboni G; Antoniazzi F; Radetti G; Musumeci C; Tatò L
    J Pediatr; 1991 Sep; 119(3):483-5. PubMed ID: 1880667
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth hormone replacement in adults: what dose?
    Ross RJ
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):401-2. PubMed ID: 8287566
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of pattern of administration of bovine growth hormone on lactational performance of dairy cows.
    McCutcheon SN; Bauman DE
    J Dairy Sci; 1986 Jan; 69(1):38-43. PubMed ID: 3754565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: Early detection of growth hormone deficiency.
    Sönksen PH; Scopes JV; West TE; Lowy C; Prunty FT; Wilson BD; Jeremiah GM
    Br Med J; 1976 Mar; 1(6011):709-10. PubMed ID: 1252897
    [No Abstract]   [Full Text] [Related]  

  • 19. Catch-up growth in early treated patients with growth hormone deficiency. Dutch Growth Hormone Working Group.
    Boersma B; Rikken B; Wit JM
    Arch Dis Child; 1995 May; 72(5):427-31. PubMed ID: 7618910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired refractoriness to growth hormone in a patient with isolated growth hormone deficiency: growth and plasma somatomedin-C response to high-dose growth hormone therapy.
    Winterer J; Chrousos G; Cassorla F; Loriaux DL
    J Pediatr; 1984 Jun; 104(6):908-11. PubMed ID: 6539376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.